The DOI matches its Crossref record; 291 of the 291 references it cites were found in a registry or an index.
Hyperexcitability and homeostasis in fragile X Syndrome.
Open accessAbstract
Fragile X Syndrome (FXS) is a leading inherited cause of autism and intellectual disability, resulting from a mutation in the FMR1 gene and subsequent loss of its protein product FMRP. Despite this simple genetic origin, FXS is a phenotypically complex disorder with a range of physical and neurocognitive disruptions. While numerous molecular and cellular pathways are affected by FMRP loss, there is growing evidence that circuit hyperexcitability may be a common convergence point that can account for many of the wide-ranging phenotypes seen in FXS. The mechanisms for hyperexcitability in FXS include alterations to excitatory synaptic function and connectivity, reduced inhibitory neuron activity, as well as changes to ion channel expression and conductance. However, understanding the impact of FMR1 mutation on circuit function is complicated by the inherent plasticity in neural circuits, which display an array of homeostatic mechanisms to maintain activity near set levels. FMRP is also an important regulator of activity-dependent plasticity in the brain, meaning that dysregulated plasticity can be both a cause and consequence of hyperexcitable networks in FXS. This makes it difficult to separate the direct effects of FMR1 mutation from the myriad and pleiotropic compensatory changes associated with it, both of which are likely to contribute to FXS pathophysiology. Here we will: (1) review evidence for hyperexcitability and homeostatic plasticity phenotypes in FXS models, focusing on similarities/differences across brain regions, cell-types, and developmental time points; (2) examine how excitability and plasticity disruptions interact with each other to ultimately contribute to circuit dysfunction in FXS; and (3) discuss how these synaptic and circuit deficits contribute to disease-relevant behavioral phenotypes like epilepsy and sensory hypersensitivity. Through this discussion of where the current field stands, we aim to introduce perspectives moving forward in FXS research.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Increased glutamatergic signaling and altered excitatory/inhibitory balance is recognized as a hallmark of FXS (Liu et al., 2022).”
From Astrocytes in fragile X syndrome (2024) · cites this paper as Liu et al., 2022
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–291 of 291
Protein synthesis levels are increased in a subset of individuals with fragile X syndrome
Jacquemont, S., Pacini, L., Jønch, A. E., Cencelli, G., Rozenberg, I., He, Y., D’Andrea, L., Pedini, G., Eldeeb, M., Willemsen, R., et al. (2018) · Human Molecular Genetics · doi:10.1093/hmg/ddy099 · Cited by 73
He, Q., Arroyo, E. D., Smukowski, S. N., Xu, J., Piochon, C., Savas, J. N., Portera‐Cailliau, C., & Contractor, A. (2018) · Molecular Psychiatry · doi:10.1038/s41380-018-0048-y · Cited by 73
Zeier, Z. R., Kumar, A., Bodhinathan, K., Feller, J. A., Foster, T. C., & Bloom, D. C. (2009) · Gene Therapy · doi:10.1038/gt.2009.83 · Cited by 72
Yang, Y., Arsenault, J., Bah, A., Krzeminski, M., Fekete, Á., Chao, O. Y.-H., Pacey, L. K. K., Wang, A. B., Forman-Kay, J. D., Hampson, D. R., et al. (2018) · Molecular Psychiatry · doi:10.1038/s41380-018-0240-0 · Cited by 72
Shang, Y., Wang, H., Mercaldo, V., Li, X., Chen, T., & Zhuo, M. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06314.x · Cited by 72
Auerbach, B. D., & Bear, M. F. (2010) · Journal of Neurophysiology · doi:10.1152/jn.00449.2010 · Cited by 71
Self-citationDeficits in Tactile Learning in a Mouse Model of Fragile X Syndrome
Arnett, M. T., Herman, D. H., & McGee, A. W. (2014) · PLoS ONE · doi:10.1371/journal.pone.0109116 · Cited by 70
Altered dendritic spine function and integration in a mouse model of fragile X syndrome
Booker, S. A., Domanski, A. P. F., Dando, O., Jackson, A. D., Isaac, J. T. R., Hardingham, G. E., Wyllie, D. J. A., & Kind, P. C. (2019) · Nature Communications · doi:10.1038/s41467-019-11891-6 · Cited by 70
Deficient tonic GABAergic conductance and synaptic balance in the fragile X syndrome amygdala
Martin, B. S., Corbin, J. G., & Huntsman, M. M. (2014) · Journal of Neurophysiology · doi:10.1152/jn.00597.2013 · Cited by 69
Patel, A. B., Loerwald, K. W., Huber, K. M., & Gibson, J. R. (2014) · Journal of Neuroscience · doi:10.1523/jneurosci.2921-13.2014 · Cited by 69
O’Donnell, C., Gonçalves, J. T., Portera‐Cailliau, C., & B, T. J. S. A. (2017) · eLife · doi:10.7554/elife.26724 · Cited by 69
Cellular Plasticity for Group I mGluR-Mediated Epileptogenesis
Bianchi, R., Chuang, S.-C., Zhao, W., Young, S. R., & Wong, R. K. S. (2009) · Journal of Neuroscience · doi:10.1523/jneurosci.5447-08.2009 · Cited by 67
Impaired Presynaptic Long-Term Potentiation in the Anterior Cingulate Cortex ofFmr1Knock-out Mice
Koga, K., Liu, M., Qiu, S., Song, Q., O'Den, G., Chen, T., & Zhuo, M. (2015) · Journal of Neuroscience · doi:10.1523/jneurosci.2644-14.2015 · Cited by 66
Gonzalez, D., Tomasek, M. P., Hays, S. A., Sridhar, V., Ammanuel, S. G., Chang, C.-W., Pawlowski, K. S., Huber, K. M., & Gibson, J. R. (2019) · Journal of Neuroscience · doi:10.1523/jneurosci.0886-19.2019 · Cited by 64
Vislay, R. L., Martin, B. S., Olmos-Serrano, J. L., Kratovac, S., Nelson, D. L., Corbin, J. G., & Huntsman, M. M. (2013) · Journal of Neuroscience · doi:10.1523/jneurosci.2764-12.2013 · Cited by 62
Fähling, M., Mrowka, R., Steege, A., Kirschner, K. M., Benko, E., Förstera, B., Persson, P. B., Thiele, B. J., Meier, J. C., & Scholz, H. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m807354200 · Cited by 61
Booker, S. A., de Oliveira, L. S., Anstey, N. J., Kozić, Z., Dando, O., Jackson, A. D., Baxter, P. S., Isom, L. L., Sherman, D. L., Hardingham, G. E., et al. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.107988 · Cited by 61
Deng, P., Carlin, D., Oh, Y. M., Myrick, L. K., Warren, S. T., Cavalli, V., & Klyachko, V. A. (2018) · Journal of Neuroscience · doi:10.1523/jneurosci.1593-18.2018 · Cited by 60
Modulators of Kv3 Potassium Channels Rescue the Auditory Function of Fragile X Mice
El‐Hassar, L., Song, L., Tan, W. J. T., Large, C., Alvaro, G. S., Santos-Sacchi, J., & Kaczmarek, L. (2019) · Journal of Neuroscience · doi:10.1523/jneurosci.0839-18.2019 · Cited by 60
McCamphill, P. K., Stoppel, L. J., Senter, R. K., Lewis, M. C., Heynen, A. J., Stoppel, D. C., Sridhar, V., Collins, K. A., Shi, X., Pan, J. Q., et al. (2020) · Science Translational Medicine · doi:10.1126/scitranslmed.aam8572 · Cited by 60
Domanski, A. P. F., Booker, S. A., Wyllie, D. J. A., Isaac, J. T. R., & Kind, P. C. (2019) · Nature Communications · doi:10.1038/s41467-019-12736-y · Cited by 59
Qin, M., Schmidt, K., Zametkin, A. J., Bishu, S., Horowitz, L. M., Burlin, T. V., Xia, Z., Huang, T., Quezado, Z., & Smith, C. B. (2013) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2012.205 · Cited by 58
Garcia-Pino, E., Gessele, N., & Koch, U. (2017) · The Journal of Neuroscience · doi:10.1523/jneurosci.2310-16.2017 · Cited by 58
D’Hulst, C., Heulens, I., der Aa, N. V., Goffin, K. E., Koole, M. J. B., Porke, K., de Velde, M. V., Rooms, L., Paesschen, W. V., Esch, H. V., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0131486 · Cited by 56
GABAergic circuit dysfunction in the Drosophila Fragile X syndrome model
Gatto, C. L., Pereira, D. E., & Broadie, K. S. (2014) · Neurobiology of Disease · doi:10.1016/j.nbd.2014.01.008 · Cited by 55
Local cortical circuit correlates of altered EEG in the mouse model of Fragile X syndrome
Goswami, S., Cavalier, S., Sridhar, V., Huber, K. M., & Gibson, J. R. (2019) · Neurobiology of Disease · doi:10.1016/j.nbd.2019.01.002 · Cited by 55
Guo, W., Molinaro, G., Collins, K. A., Hays, S. A., Paylor, R. E., Worley, P. F., Szumlinski, K. K., & Huber, K. M. (2016) · Journal of Neuroscience · doi:10.1523/jneurosci.2921-15.2016 · Cited by 54
Lauer, A. M., Behrens, D., & Klump, G. M. (2017) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2017.03.009 · Cited by 53
Zhong, L. R., Chen, X., Park, E., Südhof, T. C., & Chen, L. (2018) · Journal of Neuroscience · doi:10.1523/jneurosci.1133-18.2018 · Cited by 53
Bonaccorso, C. M., Spatuzza, M., Di Marco, B., Gloria, A., Barrancotto, G., Cupo, A., Musumeci, S. A., D'Antoni, S., Bardoni, B., & Catania, M. V. (2015) · International Journal of Developmental Neuroscience · doi:10.1016/j.ijdevneu.2015.02.004 · Cited by 52
Homeostatic Intrinsic Plasticity Is Functionally Altered in Fmr1 KO Cortical Neurons
Bülow, P., Murphy, T. J., Bassell, G. J., & Wenner, P. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.01.035 · Cited by 50
Routh, B. N., Rathour, R. K., Baumgardner, M. E., Kalmbach, B. E., Johnston, D., & Brager, D. H. (2017) · The Journal of Physiology · doi:10.1113/jp274258 · Cited by 48
Franco, L. M., Okray, Z., Linneweber, G. A., Hassan, B. A., & Yaksi, E. (2017) · Current Biology · doi:10.1016/j.cub.2017.02.065 · Cited by 48
The Relationship Between Loudness and Reaction Time in Normal Hearing Listeners
Marshall, L., & Brandt, J. F. (1980) · Acta Oto-Laryngologica · doi:10.3109/00016488009131721 · Cited by 48
Gamma power abnormalities in a Fmr1-targeted transgenic rat model of fragile X syndrome
Kozono, N., Okamura, A., Honda, S., Matsumoto, M., & Mihara, T. (2020) · Scientific Reports · doi:10.1038/s41598-020-75893-x · Cited by 47
Hyperexcitability and impaired intracortical inhibition in patients with fragile-X syndrome
Morin‐Parent, F., Champigny, C. M., Lacroix, A., Corbin, F., & Lepage, J. (2019) · Translational Psychiatry · doi:10.1038/s41398-019-0650-z · Cited by 46
Reversal of sensorimotor gating abnormalities in Fmr1 knockout mice carrying a human Fmr1 transgene.
Paylor, R., Yuva-Paylor, L. A., Nelson, D. L., & Spencer, C. M. (2008) · Behavioral Neuroscience · doi:10.1037/a0013047 · Cited by 46
Yun, S., Platholi, J., Flaherty, M. S., Fu, W., Kottmann, A. H., & Tóth, M. (2006) · Brain Research · doi:10.1016/j.brainres.2006.06.086 · Cited by 44
Carreño-Muñoz, M. I., Martins, F., Medrano, M., Aloisi, E., Pietropaolo, S., Dechaud, C., Subashi, E., Bony, G., Ginger, M. R., Moujahid, A., et al. (2017) · Neuropsychopharmacology · doi:10.1038/npp.2017.149 · Cited by 44
The developmental roles of FMRP
Till, S. M. (2010) · Biochemical Society Transactions · doi:10.1042/bst0380507 · Cited by 43
Suhl, J. A., & Warren, S. T. (2015) · Journal of Experimental Neuroscience · doi:10.4137/jen.s25524 · Cited by 43
Morgan, P. J., Bourboulou, R., Filippi, C., Koenig, J., & Epsztein, J. (2019) · eLife · doi:10.7554/elife.49915 · Cited by 42
mGluR5 Negative Modulators for Fragile X: Treatment Resistance and Persistence
Stoppel, D. C., McCamphill, P. K., Senter, R. K., Heynen, A. J., & Bear, M. F. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.718953 · Cited by 42
Lee, K. Y., Jewett, K. A., Chung, H. J., & Tsai, N. (2018) · Human Molecular Genetics · doi:10.1093/hmg/ddy189 · Cited by 41
Self-citationGABABreceptor‐mediated feed‐forward circuit dysfunction in the mouse model of fragile X syndrome
Wahlstrom‐Helgren, S., & Klyachko, V. A. (2015) · The Journal of Physiology · doi:10.1113/jp271190 · Cited by 40
Genetic Animal Models for Autism Spectrum Disorder
Schroeder, J. C., Reim, D., Boeckers, T. M., & Schmeißer, M. J. (2015) · Current topics in behavioral neurosciences · doi:10.1007/7854_2015_407 · Cited by 40
FMRP(1–297)-tat restores ion channel and synaptic function in a model of Fragile X syndrome
Zhan, X., Asmara, H., Cheng, N., Sahu, G., Sanchez, E., Zhang, F., Zamponi, G. W., Rho, J. M., & Turner, R. W. (2020) · Nature Communications · doi:10.1038/s41467-020-16250-4 · Cited by 39
Beston, B. R., Jones, D. G., & Murphy, K. M. (2010) · Frontiers in Synaptic Neuroscience · doi:10.3389/fnsyn.2010.00138 · Cited by 38
Groß, C., Banerjee, A., Tiwari, D., Longo, F., White, A. R., Allen, A. G., Schroeder, L. M., Krzeski, J. C., Elsayed, N. A., Puckett, R. E., et al. (2018) · Neuropsychopharmacology · doi:10.1038/s41386-018-0150-5 · Cited by 38
Robust and replicable measurement for prepulse inhibition of the acoustic startle response
Miller, E. A., Kastner, D. B., Grzybowski, M. N., Dwinell, M. R., Geurts, A. M., & Frank, L. M. (2020) · Molecular Psychiatry · doi:10.1038/s41380-020-0703-y · Cited by 38
Habituation of reflexive and motivated behavior in mice with deficient BK channel function
Typlt, M., Mirkowski, M., Azzopardi, E., Ruth, P., Pilz, P. K. D., & Schmid, S. (2013) · Frontiers in Integrative Neuroscience · doi:10.3389/fnint.2013.00079 · Cited by 36
Fragile X syndrome and model organisms: identifying potential routes of therapeutic intervention
Bhogal, B., & Jongens, T. A. (2010) · Disease Models & Mechanisms · doi:10.1242/dmm.002006 · Cited by 36
Jewett, K. A., Zhu, J., & Tsai, N. (2015) · Journal of Neurochemistry · doi:10.1111/jnc.13271 · Cited by 35
Self-citationAuditory hypersensitivity and processing deficits in a rat model of fragile X syndrome
Auerbach, B. D., Manohar, S., Radziwon, K. E., & Salvi, R. (2021) · Neurobiology of Disease · doi:10.1016/j.nbd.2021.105541 · Cited by 34
Self-citationLimbic Epileptogenesis in a Mouse Model of Fragile X Syndrome
Qiu, L.-F., Lu, T., Hu, X.-L., Yi, Y., Liao, W., & Xiong, Z. (2008) · Cerebral Cortex · doi:10.1093/cercor/bhn163 · Cited by 33
Human pluripotent stem cell models of Fragile X syndrome
Bhattacharyya, A., & Zhao, X. (2015) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2015.11.011 · Cited by 33
Danesi, C., Achuta, V. S., Corcoran, P., Peteri, U., Turconi, G., Matsui, N., Albayrak, I., Rezov, V., Isaksson, A., & Castrén, M. L. (2018) · Stem Cell Reports · doi:10.1016/j.stemcr.2018.11.003 · Cited by 33
Brandalise, F., Kalmbach, B. E., Mehta, P., Thornton, O., Johnston, D., Zemelman, B. V., & Brager, D. H. (2020) · Journal of Neuroscience · doi:10.1523/jneurosci.1670-19.2020 · Cited by 32
FMRP-dependent Mdm2 dephosphorylation is required for MEF2-induced synapse elimination
Tsai, N., Wilkerson, J. R., Guo, W., & Huber, K. M. (2016) · Human Molecular Genetics · doi:10.1093/hmg/ddw386 · Cited by 31
Self-citationKokash, J., Alderson, E. M., Reinhard, S. M., Crawford, C. A., Binder, D. K., Ethell, I. M., & Razak, K. A. (2019) · Brain Research · doi:10.1016/j.brainres.2019.05.029 · Cited by 31
Zhao, W., Chuang, S.-C., Bianchi, R., & Wong, R. K. S. (2011) · Journal of Neuroscience · doi:10.1523/jneurosci.2915-10.2011 · Cited by 29
Wong, H., Hooper, A. W. M., Niibori, Y., Lee, S. J., Hategan, L. A., Zhang, L., Karumuthil‐Melethil, S., Till, S. M., Kind, P. C., Danos, O., et al. (2020) · Neurobiology of Disease · doi:10.1016/j.nbd.2020.105118 · Cited by 29
Golden, C. E. M., Breen, M. S., Koro, L., Sonar, S., Niblo, K., Browne, A., Burlant, N., Di Marino, D., De Rubeis, S., Baxter, M. G., et al. (2019) · Cerebral Cortex · doi:10.1093/cercor/bhz029 · Cited by 29
Fragile X Mental Retardation Protein Regulates Olfactory Sensitivity But Not Odorant Discrimination
Nitenson, A. S., Stackpole, E. E., Truszkowski, T. L. S., Midroit, M., Fallon, J. R., & Bath, K. G. (2015) · Chemical Senses · doi:10.1093/chemse/bjv019 · Cited by 28
Effect of genetic background on acoustic startle response in fragile X knockout mice
Errijgers, V., Fransén, E., D’Hooge, R., Deyn, P. P. D., & Kooy, R. F. (2008) · Genetics Research · doi:10.1017/s0016672308009415 · Cited by 27
Activity-dependent development of GABAergic synapses
Oh, W. C., & Smith, K. R. (2018) · Brain Research · doi:10.1016/j.brainres.2018.11.014 · Cited by 27
Characterization of Auditory and Binaural Spatial Hearing in a Fragile X Syndrome Mouse Model
McCullagh, E. A., Poleg, S., Greene, N. T., Huntsman, M. M., Tollin, D. J., & Klug, A. (2020) · eNeuro · doi:10.1523/eneuro.0300-19.2019 · Cited by 26
McCullagh, E. A., Salcedo, E. E., Huntsman, M. M., & Klug, A. (2017) · The Journal of Comparative Neurology · doi:10.1002/cne.24290 · Cited by 26
Postsynaptic FMRP Regulates Synaptogenesis In Vivo in the Developing Cochlear Nucleus
Wang, X., Zorio, D. A. R., Schecterson, L. C., Lu, Y., & Wang, Y. (2018) · Journal of Neuroscience · doi:10.1523/jneurosci.0665-18.2018 · Cited by 24
Rodrı́guez, G., Mesik, L., Gao, M., Parkins, S., Saha, R., & Lee, H. (2019) · Journal of Neuroscience · doi:10.1523/jneurosci.2117-18.2019 · Cited by 24
Failed Stabilization for Long-Term Potentiation in the Auditory Cortex of Fmr1 Knockout Mice
Yang, S., Yang, S., Park, J.-S., Kirkwood, A., & Bao, S.-W. (2014) · PLoS ONE · doi:10.1371/journal.pone.0104691 · Cited by 23
Experience-dependent weakening of callosal synaptic connections in the absence of postsynaptic FMRP
Zhang, Z., Gibson, J. R., & Huber, K. M. (2021) · eLife · doi:10.7554/elife.71555 · Cited by 22
Gaboxadol in Fragile X Syndrome: A 12-Week Randomized, Double-Blind, Parallel-Group, Phase 2a Study
Budimirovic, D. B., Dominick, K. C., Gabis, L. V., Adams, M., Adera, M., Huang, L., Ventola, P. E., Tartaglia, N. R., & Berry‐Kravis, E. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.757825 · Cited by 21
Cowley, B. U., Kirjanen, S., Partanen, J. V., & Castrén, M. L. (2016) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2016.00353 · Cited by 20
Genetic background mutations drive neural circuit hyperconnectivity in a fragile X syndrome model
Kennedy, T., Rinker, D. C., & Broadie, K. S. (2020) · BMC Biology · doi:10.1186/s12915-020-00817-0 · Cited by 19
Status epilepticus in fragile X syndrome
Gauthey, M., Poloni, C. B., Ramelli, G., Roulet‐Perez, E., & Korff, C. M. (2010) · Epilepsia · doi:10.1111/j.1528-1167.2010.02761.x · Cited by 18
Fragile X syndrome and epilepsy
Qiu, L.-F., Hao, Y.-H., Li, Q., & Xiong, Z. (2008) · Neuroscience Bulletin · doi:10.1007/s12264-008-1221-0 · Cited by 18
Paradoxical effect of baclofen on social behavior in the fragile X syndrome mouse model
Zeidler, S., Pop, A. S., Jaafar, I. A., de Boer, H., Buijsen, R. A. M., de Esch, C. E. F., Nieuwenhuizen‐Bakker, I., Hukema, R. K., & Willemsen, R. (2018) · Brain and Behavior · doi:10.1002/brb3.991 · Cited by 17
Structural and Functional Abnormalities in the Olfactory System of Fragile X Syndrome Models
Bodaleo, F. J., Tapia-Monsalves, C., Rio, C. A. C.-D., González-Billault, C. E., & Nunez-Parra, A. (2019) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2019.00135 · Cited by 17
Dysregulation and restoration of homeostatic network plasticity in fragile X syndrome mice
Jewett, K. A., Lee, K. Y., Eagleman, D. E., Soriano, S., & Tsai, N. (2018) · Neuropharmacology · doi:10.1016/j.neuropharm.2018.06.011 · Cited by 15
Self-citationLiu, D.-C., Lee, K. Y., Lizarazo, S., Cook, J. K., & Tsai, N. (2021) · Neurobiology of Disease · doi:10.1016/j.nbd.2021.105450 · Cited by 15
Self-citationUsing auditory reaction time to measure loudness growth in rats
Radziwon, K. E., & Salvi, R. (2020) · Hearing Research · doi:10.1016/j.heares.2020.108026 · Cited by 14
Erratum: Genetic Otx2 mis-localization delays critical period plasticity across brain regions
Lee, H. H. C., Bernard, C., Ye, Z., Acampora, D., Simeone, A., Prochiantz, A., Di Nardo, A. A., & Hensch, T. K. (2017) · Molecular Psychiatry · doi:10.1038/mp.2017.83 · Cited by 14
Pak, A., Kissinger, S. T., & Chubykin, A. A. (2021) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2021.668230 · Cited by 13
Svalina, M. N., Guthman, E. M., Rio, C. A. C.-D., Kushner, J. K., Baca, S. M., Restrepo, D., & Huntsman, M. M. (2021) · eNeuro · doi:10.1523/eneuro.0113-21.2021 · Cited by 12
González-Rodríguez, E., Jaramillo‐Rangel, G., & Barrera-Saldaña, H. A. (1997) · American Journal of Medical Genetics · doi:10.1002/(sici)1096-8628(19971112)72:4 · Cited by 10
Motanis, H., & Buonomano, D. V. (2020) · Scientific Reports · doi:10.1038/s41598-020-71333-y · Cited by 10
Wahlstrom‐Helgren, S., & Klyachko, V. A. (2016) · Journal of Neurophysiology · doi:10.1152/jn.00413.2016 · Cited by 7
Homeostatic Inhibitory Control of Cortical Hyperexcitability in Fragile X SyndromePreprint
Rio, C. A. C.-D., Nunez-Parra, A., Freedman, S. D., Restrepo, D., & Huntsman, M. M. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/459511 · Cited by 1
Irwin (2001) · doi:10.1002/1096-8628(20010115)98:2
Miller (1999) · doi:10.1002/(sici)1096-8628(19990402)83:4
Flagged first, then by citations
Research works printed but not linked: 1
- Zhang, 2021, FMRP regulates experience-dependent maturation of callosal synaptic connections and bilateral cortical synchrony, BioRxiv, 10.1101/2021.06.25.449490 · DOI
Cited by
Sorted by citations
Beyond controlling cell size: functional analyses of S6K in tumorigenesis
Wu, X., Xie, W., Xie, W., Wei, W., & Guo, J. (2022) · Cell Death and Disease · doi:10.1038/s41419-022-05081-4 · Cited by 96
Lipid-Based Molecules on Signaling Pathways in Autism Spectrum Disorder
Yui, K., Imataka, G., & Yoshihara, S. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23179803 · Cited by 27
Early molecular layer interneuron hyperactivity triggers Purkinje neuron degeneration in SCA1
Pilotto, F., Douthwaite, C., Diab, R., Ye, X., qassab, Z. A., Tietje, C., Mounassir, M., Odriozola, A., Thapa, A., Buijsen, R. A. M., et al. (2023) · Neuron · doi:10.1016/j.neuron.2023.05.016 · Cited by 19
Montagner, P. S. S., Medeiros, W., da Silva, L. C. R., Borges, C. N., Brasil-Neto, J. P., Barbosa, V. D. D. S., Caixeta, F. V., & Malcher‐Lopes, R. (2023) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2023.1210155 · Cited by 21
Shing, N., Walker, M. C., & Chang, P. (2022) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2022.107683 · Cited by 19
Metadata
- Authors
- Liu, X., Kumar, V., Tsai, N.-P., & Auerbach, B. D.
- Affiliations
- University of Illinois Urbana-Champaign (US)
- Corresponding author
- Auerbach, Benjamin D.
- Venue
- Frontiers in Molecular Neuroscience
- Publisher
- Frontiers Media SA
- Published
- 2022-01-06
- Volume
- 14
- Pages
- 805929-805929
- ISSN
- 1662-5099 (ISSN-L)
- PMC
- PMC8770333
- OpenAlex
- W4205495648
- Cited by
- 53
- References
- 291
- Citations by year
- 2026: 9 · 2025: 13 · 2024: 10 · 2023: 11 · 2022: 8
- FWCI
- 6.33
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Frontiers in Molecular Neuroscience (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- National Institute of Mental Health (R01MH124827)
- National Institute on Deafness and Other Communication Disorders (K01DC018310)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetics and Neurodevelopmental Disorders
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Life Sciences › Neuroscience › Cognitive Neuroscience › Autism Spectrum Disorder Research
- Keywords
- fragile X syndrome, FMRP, neuronal hyperexcitability, neuronal homeostasis, homeostatic plasticity, inhibitory neurons, ion channels, activity-dependent plasticity, autism spectrum disorder, intellectual disability, epilepsy, sensory hypersensitivity, circuit dysfunction
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review